LEESBURG, Va. / Jul 11, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery. The software can be used for craniotomies, skull base and transsphenoidal procedures, shunt placements, and biopsies.
“With Cranial Guidance Software powered by Q, neurosurgeons have more surgical planning and guidance capabilities than ever before, with a special focus on biopsies and shunt placements,” said Robbie Robinson, president of Stryker’s Spine division. “This technology has the potential to become the standard of care and a possible means to increase accuracy and efficiency in the operating room.”
The Q Guidance System with Cranial Guidance Software uses both active and passive tracking technology to provide groundbreaking planning and guidance capabilities that include:
“With Stryker’s new camera technology, we were able to quickly register patients using the CranialMask Tracker,” said Dr. J.D. Day, M.D. of UAMS Health in Little Rock, Arkansas. “The new user interface and workflows are slick, and our staff loves the intuitive new views like 3D targeting and the new skull stripping feature.”
The Q Guidance System with Cranial Guidance Software was used at six early product surveillance sites in May 2023.
Learn more about this new technology at strykeronegiantleap.com.
References:
1. Stryker data on file.
About Stryker
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.
More information is available at www.stryker.com.
Last Trade: | US$359.73 |
Daily Change: | 0.75 0.21 |
Daily Volume: | 624,469 |
Market Cap: | US$137.090B |
September 20, 2024 September 17, 2024 September 11, 2024 August 22, 2024 August 12, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB